Look up a health practitioner

Close

Check if your health practitioner is qualified, registered and their current registration status
26 search results for
  • March 2021

    Pharmacy Board
    Methotrexate is an anti-inflammatory drug. It is also a cytotoxic used in cancer chemotherapy. ... The patient’s general practitioner prescribed methotrexate to treat a…
    Date published 26 September 2023
    www.pharmacyboard.gov.au/News/Newsletters/March-2021.aspx
  • Methotrexate and patient harm: an analysis of notifications involving oral methotrexate in Australia 2010 to 2019

    Australian Health Practitioner Regulation Agency
    Data was coded to identify. Key Messages. • Methotrexate is a high-risk medicine. • ... Oral cytotoxic medicines, including methotrexate, must be packed separately to a…
    Date published 22 March 2021
    Download document
    pdf document
    PDF
    199.2KB
    View as HTML
  • 2020/21 annual summary

    Pharmacy Board
    The Pharmacy Board of Australia published an analysis of notifications involving oral methotrexate. ... The Board started stakeholder engagement to explore opportunities for…
    Date published 1 January 2011
    www.pharmacyboard.gov.au/About/Annual-report/2021-annual-summary.aspx
  • Tribunal reprimands pharmacist for unsafe dispensing

    Australian Health Practitioner Regulation Agency
    In January 2015, pharmacist Jennifer Barca dispensed an unsafe dose of methotrexate to a patient who subsequently died from complications of methotrexate toxicity. ... A…
    Date published 1 January 2001
    www.ahpra.gov.au/News/2021-01-22-Tribunal-reprimands-pharmacist.aspx
  • Research, strategy and policy

    Australian Health Practitioner Regulation Agency
    a review of notifications about pharmacists involving the dispensing of oral methotrexate.
    Date published 1 January 2011
    www.ahpra.gov.au/Publications/Annual-reports/Annual-Report-2020/Research-strategy.aspx
  • Analysis of notifications involving oral methotrexate – summary report published

    Pharmacy Board
    The analysis found that:. since 2010 there have been 28 notifications involving pharmacists and methotrexate. ... while the number of notifications involving oral…
    Date published 24 March 2021
    www.pharmacyboard.gov.au/News/2021-03-24-summary-report-published.aspx
  • October 2014

    Pharmacy Board
    The prescription for methotrexate was correctly dispensed by a pharmacist for packaging into a DAA for use by the patient. ... The setting out of the patient’s medication…
    Date published 26 September 2023
    www.pharmacyboard.gov.au/News/Newsletters/October-2014.aspx
  • Meeting of the Pharmacy Board of Australia - 23 May 2014

    Pharmacy Board
    The prescription for methotrexate was correctly dispensed by a pharmacist for packaging into a dose administration aid (DAA) for use by the patient. ... The setting out of…
    Date published 13 June 2014
    Download document
    pdf document
    PDF
    273.7KB
    View as HTML
  • June 2016

    Pharmacy Board
    Methotrexate incidents. Following recent publication of research in the Medical Journal of Australia about methotrexate-related adverse events, the Board reiterates its…
    Date published 26 September 2023
    www.pharmacyboard.gov.au/News/Newsletters/June-2016.aspx
  • Professional Practice Issues

    Pharmacy Board
    Methotrexate and patient harm - an analysis of notifications involving oral methotrexate in Australia 2010 to 2019 (195 KB,PDF).
    Date published 1 January 2004
    www.pharmacyboard.gov.au/News/Professional-Practice-Issues.aspx
Displaying results 1 to 10 of 26
 
Page reviewed 28/07/2015